Illumina, Inc. - Common Stock (NQ:ILMN)

273.04 +7.32 (+2.75%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

39 40 Next >

Nasdaq, S&P 500 Futures Rise Ahead Of Apple Earnings: Why This Analyst Thinks 'No Cut' Scenario May Not Be Negative For Market ↗

May 02, 2024

U.S. stocks look to push ahead on a positive path, now that the Federal Reserve’s rate decision is in the rearview mirror. Major index futures point to a positive open on Thursday.

Via Benzinga

Topics Stocks

3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire ↗

May 02, 2024

Pay close attention to gene editing stocks. By 2028, according to MarketsandMarkets, the market could be worth about $10.6 billion.

Via InvestorPlace

Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week ↗

April 29, 2024

With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages.

Via Benzinga

Topics Stocks

Looking Into Illumina's Recent Short Interest ↗

April 12, 2024

Via Benzinga

Leading the Way: Swoop Named Provider of Choice for Employee Shuttling by Fortune 500 & Renowned Technology Companies

March 20, 2024

LOS ANGELES - March 20, 2024 - PRLog -- Swoop Inc. the leading group transportation service provider, is proud to announce its recent success in providing best-in-class employee shuttling services to...

Via PRLog

Critical Insights From Illumina Analyst Ratings: What You Need To Know ↗

February 14, 2024

Via Benzinga

Jim Cramer Rejects Illumina As 'It's Not Well-Run,' Recommends Buying This Tech Stock 'Right Here, Right Now' ↗

April 30, 2024

Jim Cramer doesn't recommend buying Dynatrace stock due to its high price. Canopy Growth is the best pot stock. BrightSpring, Illumina, and Bank of America also mentioned. Cramer recommends buying Palo...

Via Benzinga

Topics Cannabis

The Cathie Wood Stock Shuffle: 4 Names She’s Loving, 3 She’s Leaving ↗

April 16, 2024

Investing with the Ark Invest guru is a roller coaster ride, but she always keeps her big ideas for the future in front of her.

Via InvestorPlace

Jim Cramer Isn't Going With This Tech Company: 'It's Complicated. I'm A Nvidia Guy' ↗

April 08, 2024

On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Uber Technologies, Inc. (NYSE: UBER).

Via Benzinga

Nasdaq’s Nosebleed Section: 3 Expensive Stocks to Sell Before It’s Too Late ↗

April 05, 2024

Investors might want to be wary and dump these expensive Nasdaq stocks to sell before their impending and potentially violent corrections.

Via InvestorPlace

Earnings Scheduled For February 8, 2024 ↗

February 08, 2024

Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million.

Via Benzinga

Large-Cap Stocks In Trouble: Here Are The 10 Worst Performers Over The Past 12 Months ↗

March 31, 2024

Over the past 12 months, 10 Large-Cap stocks have underperformed all others.

Via Talk Markets

Why Illumina Stock Zoomed Higher on Thursday ↗

March 21, 2024

The company's chances for winning an important legal battle have improved dramatically.

Via The Motley Fool

EU Antitrust Regulators Overstepped in Illumina-Grail Deal, Says Court Adviser ↗

March 21, 2024

EU antitrust advisor criticizes decision blocking Illumina's $7.1 billion bid for Grail, citing overreach. Impact on Qualcomm deal scrutinized. Commission's jurisdiction challenged amid legal battles....

Via Benzinga

Icahn’s All-In: 3 Stocks Billionaire Carl Icahn Is Betting Big On ↗

March 18, 2024

Carl Icahn, the corporate raider turned activist investor, has put most of his master limited partnership' portfolio into just three stocks.

Via InvestorPlace

Gene Sequencing Firm Illumina Escapes Carl Icahn's Second Proxy Battle Amid Grail Divestment Efforts ↗

March 13, 2024

Carl Icahn halts new challenge to Illumina's board, sparing the gene sequencing giant a second proxy battle. Focus shifts to legal action over Grail acquisition.

Via Benzinga

Earnings Crushers: Unveiling Q4’s 3 Top Stock Superstars ↗

March 11, 2024

Although there were many earnings winners in the fourth quarter, these three picks have more promise than their counterparts.

Via InvestorPlace

3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise ↗

March 07, 2024

Discover the pivotal roles of cancer-fighting biotech stocks that are advancing cancer research and subsequently, their financial growth.

Via InvestorPlace

7 No-Frills Dividend Stocks for Your Must-Own List ↗

March 05, 2024

Income investors don't need to invest in risky businesses when no-frills dividend stocks get the job done just fine.

Via InvestorPlace

Over $1M Bet On This Industrial Stock? Check Out These 4 Stocks Insiders Are Buying ↗

February 27, 2024

Although U.S. stocks closed lower on Monday, there were a few notable insider trades.

Via Benzinga

ILLUMINA ALERT: Bragar Eagel & Squire, P.C. is Investigating Illumina, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

February 26, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Why Illumina Stock Mashed the Market on Monday ↗

February 26, 2024

Investors usually get more bullish when a top manager buys more heavily into their company.

Via The Motley Fool

Activist Investor Alert: The Top 3 Stocks Carl Icahn Is Targeting in 2024 ↗

February 23, 2024

For those who want to invest alongside the legendary financier and activist investor, these are the top Carl Icahn stocks right now.

Via InvestorPlace

3 Gene Editing Stocks With Unprecedented Surge Potential ↗

February 13, 2024

While CRISPR will certainly be exciting to watch, here are some other gene-editing stocks with unprecedented surge potential.

Via InvestorPlace

DNA Sequencing Kit Provider Illumina's Q4 Earnings Edge Above Street Estimates, Works To Resolve GRAIL Quickly ↗

February 09, 2024

Illumina exceeds Q4 2023 expectations with $1.12 billion sales, up 4% YoY. CEO Jacob Thaysen anticipates growth and outlines strategic priorities for 2024.

Via Benzinga

US Stocks Set To Open Higher, Finish Week Stronger Amid Mixed Earnings: Analyst Sees Another Leg-Up Ahead Of Historically Weak March ↗

February 09, 2024

The upward momentum that has been in play in recent sessions could cushion the market, especially as most major indices are in uncharted territory.

Via Benzinga

Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

February 09, 2024

Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) fell sharply during Friday’s session following third-quarter results.

Via Benzinga

Expedia Reports Q4 Results, Joins Pinterest, Affirm Holdings And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

February 09, 2024

U.S. stock futures were mixed this morning, with the Dow futures trading lower by around 15 points on Friday.

Via Benzinga

Topics Stocks

S&P 500 Tests Resistance At 5,000, ARM Rockets, Oil Rebounds: What's Driving Markets Thursday? ↗

February 08, 2024

Major U.S. stock averages traded on a mixed note at midday in New York, with the S&P 500 grappling with the psychological resistance level of 5,000, while the tech-heavy Nasdaq 100 managed to reach...

Via Benzinga

Topics Stocks

US Stocks On Backfoot Amid Overbought Levels, S&P 500 Eyes Break Above 5K: Analyst Sees 'Dramatically Higher' Market Surge From Rally This Year ↗

February 08, 2024

Focus now shifts to the jobless claims report for labor market insights, with market overbought levels prompting a defensive stance.

Via Benzinga

Topics Stocks

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

39 40 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.